5^4 
Progress  in  Pharmacy. 
f  Am.  Jour.  Pharm. 
\    December,  1909. 
PROGRESS  IN  PHARMACY. 
By  M.  I.  WilberTj  Washington,  D.C. 
A  QUARTERLY  REVIEW  OF  SOME  OF  THE  MORE  INTERESTING  LITERA- 
TURE RELATING  TO  PHARMACY  AND  MATERIA  MEDIC  A. 
The  Pharmacopoeia  of  the  United  States  and  the  coming  Phar- 
macopoeia Revision  Convention  are  attracting  the  attention  of 
physicians  as  well  as  pharmacists,  and  an  unbiased  observer  must 
admit  that  physicians  are  devoting  rather  more  serious  thought  to 
pharmacopceial  problems  than  are  pharmacists. 
This  fact  was  emphasized  at  a  recent  meeting  of  the  City  of 
Washington  Branch  of  the  American  Pharmacopceial  Association, 
where  it  was  shown  that  while  the  very  comprehensive  report  of 
the  A.  Ph.  A.  Committee  on  the  U.S. P.  was  not  even  read,  the 
reports  of  similar  committees  of  the  A.M. A.  were  read  and  dis- 
cussed at  some  length. 
The  several  reports  of  special  committees  on  the  Pharmacopoeia 
of  the  United  States  of  America  that  were  presented  at  the  sec- 
tion meetings  of  the  American  Medical  Association  were  published 
in  the  Journal  of  the  American  Medical  Association  (September  4, 
1909,  pp.  791-796),  and  were  further  commented  on  in  the  same 
journal  (October  30,  1909,  pp.  1491  and  1496). 
Another  article  bearing  on  the  same  subject  appears  in  the  Jour- 
nal of  the  A.M. A.  for  November  6,  1909  (pp.  1 543-1 546),  and  is 
well  worth  careful  study  on  the  part  of  pharmacists. 
That  our  English  cousins  are  more  wide-awake  to  what  is 
going  on  in  this  country  than  many  of  our  own  pharmaceutical  edi- 
tors is  evidenced  by  an  editorial  in  the  Pharmaceutical  Journal 
(London,  Sept.  18,  1909,  pp.  359-360),  which  discusses  the  report  of 
the  Committee  on  the  U.S. P.  of  the  Section  on  Practice  of  the 
A.M.A. 
The  attention  given  to  pharmacopceial  matters  at  the  meeting 
of  the  N.W.D.A.  is  also  worth  bringing  to  the  attention  of  members 
of  the  drug  trade  generally,  and  the  report  of  the  Committee  on 
Drug-standards  of  that  association  is  well  worth  studying.  The 
same  is  true  of  the  report  of  the  A.Ph.A.  Committee  on  the  U.S. P., 
which  is  printed  in  full  in  the  BuUftin  of  the  American 
Pharmaceutical  Association  for  November. 
The  report  of  the  A.Ph.A.  Committee  on  the  National  Formu- 
